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1. Introduction 
Pharmacokinetic (PK) studies are a crucial part of drug discovery. These studies require 
analysis of high numbers of plasma or serum samples from animals and humans to measure 
concentrations of peptide-/protein-drugs. The demands to assays are that they have a high 
capacity, only need low sample volumes, have a broad working range to avoid testing too 
many dilutions of samples, and have a good sensitivity. They have to be fast to develop and 
preferentially be more or less ready “on the shelf”. When new drug candidates like 
peptides, proteins or peptide-/protein-analogues are developed it is important that assays 
are available to all relevant peptide-/protein-drugs in due time.  
Immunoassays will often be the method of choice for this kind of testing. Especially the 
luminescent oxygen channeling immunoassay (LOCI) fulfill most requirements to PK testing 
of peptide and protein drugs (Poulsen & Jensen, 2007). LOCI™ is a trade name of Siemens. 
Perkin Elmer is using the name AlphaLISA for the technology. This superior technology also 
has its limitations. To release the full potential of LOCI sandwich assays monoclonal 
antibodies (MCA) are needed due to the high percentage (100%) of specific antibody.  
It may take long time and it may be difficult to generate antibodies against relevant parts of 
a drug molecule and to obtain monoclonal antibodies which will cooperate in a sandwich. 
Developing polyclonal antibodies is much faster than developing monoclonal antibodies 
thus allowing faster establishment of assays. Furthermore polyclonal antibodies may 
contain many antibody specificities against an analyte molecule and may allow using many 
different species for antibody generation which may give more specificity options.  
The LOCI sandwich assay requires high concentration and high density of antibodies on 
beads. Since the fraction of specific antibodies in a polyclonal antibody (PCA) is low (1-5%) 
(Lipman et al., 2005) the density of specific antibodies on the A beads will with PCAs be 
reduced to 5% or less compared to MCAs. The binding capacity of SA-D beads and 
limitations of the SA-D bead concentrations means that high concentrations of biotin-
antibody is not tolerated. This means that use of PCA in LOCI which will require high 
concentrations of biotin-PCA to have enough specific antibody is not feasible or suboptimal. 
Immunopurification will thus be required to have enough specific antibodies in the assay. 
The immunopurification is time and resource consuming. It results in loss of antibody and 
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potential loss of high avidity antibodies. Finally the antibodies may be partially denatured 
resulting in increased non-specific binding of the purified antibodies. To avoid this we have 
developed the wash-LOCI, a semi-heterogeneous LOCI version allowing direct use of high 
concentrations of PCA, and giving binding of a high amount of specific antibodies.  
The new assay is based on the LOCI technology and is able to run with the same reagents, 
readers and robotic system as the normal LOCI and is only slightly more cumbersome to 
run than LOCI. 
The wash-LOCI version allows removing non-bound biotin-PCA before addition of SA-D 
beads. A separation could be done by binding antibody-A beads to the well bottom, by a 
filtration step or by using magnetic beads (Hall et al., 1999; Koskinen et al., 2004; Kulmala et 
al., 2002; McCrindle et al., 1985; Namba et al., 2000; Obenauer-Kutner et al., 1997; Okano et 
al., 1992; Sardesai et al., 2009; Sin et al., 2006; Soukka et al., 2001). All the described methods 
are based on particulate labels. Since it turned out to be impossible to find 384-well filter 
plates with a pore size trapping the beads without being clogged by plasma this approach 
was given up. The LOCI A beads are not magnetic so to use magnets it would be necessary 
to couple the A beads to magnetic beads. The magnetic beads might give optical shielding 
problems and the process would be more complicated. We therefore decided to go for the 
version with A beads coupled directly to the well bottom. 
This work was done with human insulin as a model system. Chicken plasma was used since 
chicken insulin cannot be measured in the assays and endogenous insulin will thus not blur 
the results.  
The LOCI technology is based on two types of latex beads. One type, the D beads, contains a 
photosensitizer. The other type, the A beads, are chemiluminescent beads (Ullman et al., 1994; 
Ullman et al., 1996). Pairs of D beads and A beads are formed in the assay through specific 
binding interactions by combining sample and the two bead types. Irradiation causes 
photosensitized formation of singlet oxygen which migrates to and activates bound 
chemiluminescent beads thereby initiating a delayed luminescence emission. The basic 
technology is homogeneous requiring no separation and no washing. It lends itself for 
miniaturization to 384 allowing low sample volumes and for high capacity measurements. 
Run as a double antibody sandwich assay it has a very good sensitivity and a very broad 
working range.  
The goal was to obtain usable LOCI assays based on a monoclonal and a polyclonal 
antibody or on a PCA pair. The PCAs must be used without immunopurification. 
Furthermore, the homogeneous LOCI is vulnerable to strong hemolysis or to inner filter 
effects or singlet oxygen quenchers in general and to hook effect at very high analyte 
concentrations. These limitations were tried avoided by modification of the LOCI assay. The 
core of this modification is anchoring the antibody-coated A-beads to the well bottom 
allowing wash/separation in the assay. 
2. Materials and methods 
2.1 Plates and plate equipment 
Plates, AlphaPlate-384 High Binding (light grey) were from Perkin Elmer. Plate centrifuge, 
Multifuge 3 S-R Hereus. Plate washer, Tecan Power Washer 384 using wash program “cell 
www.intechopen.com
Wash-LOCI – A Semi-Heterogeneous Version  
of the LOCI Technology Allowing Removal of Unbound Material After Each Assay Step 
 
261 
wash 384_51”. Plate shaker, Titramax 100 from Heidolph using speed 6. Plate reader, 
Envision Turbo Alpha from Perkin Elmer. 
2.2 Reagents 
Unconjugated Eu-acceptor beads (A beads) and streptavidin-coated donor beads (SA-D 
beads) were from Perkin Elmer. 
The monoclonal antihuman insulin antibodies HUI018, HUI001, and OXI005 were from 
Novo Nordisk. The polyclonal guinea pig anti-insulin antisera were from Fitzgerald, 
Millipore, Peninsula, and Novo Nordisk. The IgG fraction from these antisera was isolated 
by protein A chromatography and is then referred to as Fz, Mill, Pen, and 4078E 
respectively. 
Antibodies were coupled to A beads as described by the manufacturer except that the 
antibody was in 0.1 M phosphate (sodium), pH 8.0, and the amount of antibody used was 
0.6 mg/mg beads. The resulting product is antibody-A beads. 
Biotinylation of antibodies was done as described by Poulsen & Jensen (2007). 
Human insulin was from Novo Nordisk. 
Normal chicken, rat and pig EDTA plasma pools were from Bioreclamation.  
2.3 Plate coating 
Plates were coated with antibody-A beads, 35 µl/well, 5 µg/ml in PBS pH 7.2. After 
addition of beads the plates were centrifuged for 2 h at 3452xg followed by incubation for 
20h at 4°C. Before use the wells were washed with wash buffer and afterwards completely 
emptied from liquid. 
2.4 Assays 
2.4.1 LOCI 
LOCI was performed as described previously (Poulsen & Jensen, 2007). In brief the assay 
was performed in 384-well plates. Five µl of test samples were added to the wells followed 
by 15 µl of a mixture of antibody-A beads and biotin-antibody. The plates were incubated 
for 1 hour at 22 °C. Then 30 µl of SA-D beads were added. After 30 minutes of incubation at 
22 °C the plates were measured on an Envision reader. 
2.4.2 Wash-LOCI  
The assay was performed in AlphaPlate-384 High Binding (light grey) 384-well plates.  
The assay buffer contained 25 mM Hepes, 50 mM NaCl, 10 mM EDTA (tripotassium salt), 2 
mg/mL Dextran T500 (Pharmacosmos, Holbaek, Denmark), 0.5% bovine serum albumin (A-
7888; Sigma-Aldrich, St. Louis, MO), 0.1% bovine gamma globulin (G-5009; Sigma-Aldrich), 
0.2 mg/mL mouse immunoglobulin (HBR1; Scantibodies Laboratories, Santee, CA), 0.1% 
(w/v) Tween 20, 0.01% Proclin 300 (Sigma-Aldrich), and 0.01% gentamycin sulphate 
(Biological Industries, Israel) and was adjusted to pH 7.4. 
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Biotin-antibody buffer was assay buffer + 0.2 M Na-Citrate + 1% guinea pig serum, pH 7.40.  
Sample dilution buffer: Assay buffer with 0.015% (w/v) Triton X-100 and 0.05% (w/v) SDS. 
Wash buffer: PBS pH 7.20 with 0.05% (w/v) Tween 20.  
The test samples and standards were diluted 1+2 in sample dilution buffer and 10 µl of this 
(3.3 µl plasma) were added to the wells. The plates were covered and incubated at 22 °C for 
1 hour with shaking. The plates were washed on the plate washer 2x with wash buffer. 
Biotin-antibody in biotin-antibody buffer (10 µL) was then added to the wells and the plates 
incubated and washed as described above. Finally 10 µl SA-D beads were added and the 
plates incubated as described above (except that it was in the dark). Immediately after this 
incubation the plates were read on an Envision without wash separation of unbound 
material utilizing the homogeneous nature of the LOCI technology.   
The concentrations in wells were as follows: 
Plasma sample 33%, biotin-antibody 4.5 nM for MCA and 80 nM for PCA, and SA-D beads 
100µg/ml. 
The results were measured on an Envision Turbo Alpha (Perkin Elmer) with 1 detector, 70 
ms excitation time and 140 ms detection time i.e. same adjustment for LOCI and wash-LOCI. 
The total processing time per 384-well plate was about 2.75 minutes, and the time for 
measuring from the 1st to the last well was about 2.33 minutes. 
If nothing else mentioned the standard conditions described above are used in the 
experiments. 
3. Results and discussion 
3.1 Wash-LOCI principle  
The principle of the wash-LOCI is illustrated in Figure 1. Accordingly the A beads coated 
with antibody are attached to the bottom of the microtiter plate. After binding of insulin 
unbound insulin is washed away.  
 
Fig. 1. Principle of wash-LOCI and LOCI. 
     LOCI         Wash-LOCI
well bottom 
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This is followed by binding of biotin-antibody and again unbound molecules are washed 
away. The last step is addition of SA-D beads and after incubation the wells are measured in 
the Envision reader without washing utilizing the proximity principle of LOCI.  
In this study wash-LOCI and normal LOCI are compared and from the figure it can be seen 
that the assays are identical except that the A beads are anchored in the wash-LOCI 
allowing for removal of unbound material by washing. The bead pairs are formed on the 
well bottom and not in suspension. This means that reading is surface reading in stead of 
suspension reading. To have the optimal surface to volume ratio the beads are bound to the 
well bottom only and not to the walls. This will also, with small sample and reagent 
volumes, result in faster assays. The Envision reader collects the signal from only a small 
part of the well bottom surface. This means that analyte bound to the bottom will be 
measured whereas analyte bound to the well walls will not be detected. Uniformity of the 
bead-coating on the bottom is crucial for this surface reading. Uniform and reproducible 
distribution of sample and reagents over the bottom are also important for that. The assay is 
run as a sequential procedure. This procedure has been found to be beneficial when a 
MCA/PCA sandwich is used (Obenauer-Kutner, 1997). The procedure removes analyte as 
well as interfering components before the biotin-antibody is added which gives a system 
different from and complementary to the LOCI assay. 
3.2 Coating of plates with antibody-A beads 
Coating was performed by centrifugation to secure that beads were coming into contact 
with the well bottom allowing them to bind.  
The volume of beads for coating must have a size securing an even distribution over the 
well bottom. Too small bead volumes for coating will result in uneven coating. During 
reading the laser light from the Envision will hit the bottom and excite the D beads bound 
resulting in light output from the A beads. An uneven layer of coated A beads will thus be 
detrimental to the assay. Furthermore, since Envision is only exciting on the well bottom it is 
important that analyte and reagents are bound on the bottom. 
Centrifugation is important for binding of beads by increasing the amount of beads bound 
and the speed of bead binding. It is important to have a high density of antibody beads on 
the bottom to have high antigen binding capacity. Centrifugation gave a more reproducible 
coating and a more uniform coating within a plate and an extra 20 h incubation following 
the centrifugation increased this positive effect. The centrifugation also prohibited or 
reduced the binding of beads to the walls.  
For all results in this work 35 µl have been used for coating but 15 µl seem to work equally 
well. Lower volumes than 15 µl should not be used since this may result in inconsistent 
coating. The optimal amount of beads added per well was found to be 185-370 ng/well.  
Since the beads are only passively bound to the bottom the stability of this binding was 
tested. After coating with beads the coated plates were pretreated by incubating with assay 
buffer for 20 hours. The coated plates were washed before and after the incubation. Then an 
assay was run. No effect of this extra treatment was observed showing that the binding of 
the beads was strong (data not shown).  
The bead-coated plates may be stored for at least 5 days at 4°C. Plate coating is thus not 
considered part of the assay. 
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3.3 Wash-LOCI and LOCI with MCA and PCA 
LOCI and wash-LOCI with MCA and PCA were developed and compared. 
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Fig. 2. Comparison of wash-LOCI and LOCI with HUI018-A beads and biotin-OXI005 in 
both assays. 
The first characterization of the wash-LOCI was done by running LOCI and wash-LOCI 
with the same two MCAs (HUI018 and OXI005) used by Poulsen & Jensen (2007). From 
Figure 2 it is clear that the wash-LOCI concept is working but that the LOCI assay is 
superior with respect to sensitivity and working range and the signal is also higher. The 
lower signal with wash-LOCI is probably related to the amount of HUI018-A beads per well 
which is higher in LOCI. On the other hand the assay performance of the wash-LOCI shows 
that the wash-LOCI concept is working well.  
A number of sandwich combinations with MCA and PCA have been investigated in the 
wash-LOCI and normal LOCI. The results are illustrated in Figure 3. The MCA pair gave 
obviously the best LOCI assay (Fig. 3 C). It can be seen that MCA on the A-beads generally 
gave the best assays (Fig. 3 A and C). In both assay versions PCA coupled to the A beads 
gave assays with lower signal, reduced sensitivity, and reduced working range (Fig. 3 B and 
D). This is ascribed to the low amount of specific antibodies in PCA which results in a lower 
binding capacity on the A beads. With respect to the biotin-antibody then the PCA gave 
lower sensitivity and range in LOCI (Fig. 3 C). This again must be due to a low 
concentration of specific antibody which can not be compensated by increasing the 
concentration of biotin-IgG because of a limited amount of SA-D beads (see also Fig. 9).  
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Fig. 3. Comparison of wash-LOCI (A and B) and LOCI (C and D) with various MCA and 
PCA combinations. The antibody pairs are shown as antibody-A bead/biotin-antibody. The 
same antibodies are used in the two assays for direct comparison.  
The SA-D bead amount has to be limited in LOCI probably because of optical problems with 
too high concentrations of SA-D beads. This means that increase of the amount of biotin PCA 
will not be possible since it will be counter-productive (see also Fig. 9). In LOCI the excess 
biotin-MCA cannot be removed meaning that excess biotin-PCA will not be bound to the SA-
D beads. In wash-LOCI biotin-antibody is bound only to antibody immobilized insulin which 
is what has to be detected. In the wash-LOCI good assays were obtained with biotin-PCA (Fig. 
3 A and B). This is because a higher concentration of biotin PCA can be used since biotin-(non-
specific)-IgG not bound to the solid phase is washed away before addition of the SA-D beads. 
This result in a high amount of specific antibodies bound to insulin on antibody-A beads. The 
assays based on a PCA-A/biotin-MCA pair were better with LOCI than with wash-LOCI (Fig. 
3 B and D). This can be explained by competition between PCA and MCA for an epitope since 
the sequential procedure in the wash-LOCI allows the PCA to bind before the MCA is added. 
LOCI functioned optimally with the two MCAs whereas in the wash-LOCI the MCA-A beads 
with biotin-Fz gave the best results (Fig. 3 A and C).  
These data confirm that without the wash separation, immunopurification of PCAs was 
necessary for their use in LOCI. Otherwise the signal level will be too low, the detection 
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limit too high and the working range too narrow. Omitting this purification step makes it 
much easier especially when many different antibodies have to be used. The wash-LOCI 
thus makes the use of PCAs in the LOCI technology much more feasible. 
Fz was the best PCA in as well LOCI as in wash-LOCI. The LOCI assay performs well with 
this antibody but wash-LOCI still shows the best sensitivity with this antibody. 
Comparison of wash-LOCI and LOCI with other polyclonal antibodies showed that wash-
LOCI had a more dramatic effect with these PCAs resulting in nice wash-LOCI assays but 
very low sensitivity assays in LOCI (Fig. 4).  
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Fig. 4. Comparison of wash-LOCI and LOCI with various biotin-PCAs (Fz, Mill, Pen, and 
4078E) combined with HUI018-A beads. The same antibodies are used in the two assays for 
direct comparison. 
It can be seen that the difference between PCAs becomes smaller in wash-LOCI probably 
because the low PCA titre i.e. lower concentration or avidity of specific antibodies was 
compensated by using higher concentrations of PCA.  
In Table 1 the performance of two different PCAs are shown in wash-LOCI and LOCI. It can 
be seen that the signal-to-noise ratio was higher with Fz in both assays. The wash-LOCI had 
higher ratios in the low concentration range whereas the LOCI had higher ratios in the high 
concentration range. For Mill the wash-LOCI had generally the best S/N ratios. The data 
indicated that the wash-LOCI had the best sensitivity with both antibodies and the broadest 
working range with Mill. The LOCI had the broadest working range with the best of the two 
PCAs i.e. Fz. 
It was possible to obtain human insulin dose-response curves in LOCI with Fz with good 
but not necessarily acceptable sensitivity. Fz was used in this study to illustrate that it is 
possible to develop good LOCI assays with PCAs with high avidity/high concentration 
specific antibodies. The advantage of wash-LOCI was much bigger with low-titer anti-
insulin PCA and with such PCAs only the wash-LOCI is working with PCA (Fig. 4). 
Figure 5 (A and B) shows the best assays obtained with the two LOCI versions. It shows that 
with the right choice of PCA in the wash-LOCI an assay which performs comparable to our 
best MCA based LOCI was obtained. It was possible to run the wash-LOCI assay with PCA 
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without immunopurification of the specific antibodies. Sensitivity and working range being 
comparable to the MCA based LOCI. The variation is smaller for the LOCI assay. 
 
 S/N 
Analyte 
concentration 
Wash-LOCI 
Fz      Mill 
LOCI 
Fz      Mill 
10000 299 217 737 49 
2500 249 134 263 33 
625 138 36 78 14 
156 54 8 22 5 
39 17 3 6 2 
10 6 1 2 1 
2 3 1 1 1 
0 1 1 1 1 
Table 1. Signal-to-noise (S/N) ratios calculated as the ratio between a signal and the 0-
concentration signal. The assays are based on HUI018-A beads and biotin-Fz or biotin-Mill.   
 
 
Fig. 5. Comparing optimal wash-LOCI and LOCI assays. Wash-LOCI with HUI001-A and 
biotin Fz and LOCI with HUI018-A and biotin-OXI005. Full concentration range, log-lin plot 
(left) and low concentration range, lin-lin plot (right). Data represent the mean of replicate 
measurements (n=4) of each calibrator ± 1 SD (error bars). 
3.4 Kinetics 
The kinetics of the wash-LOCI is due to diffusion distance in the semi-heterogeneous 
procedure different from the kinetics of the homogeneous LOCI. The reason for that is the 
diffusion distance to the immobilized beads on the bottom of the wells and the sequential 
nature of the wash-LOCI. However the low volume of sample and reagents in wash-LOCI 
and a favorable surface-to-volume ratio gave a shorter distance to diffuse; resulting in 
relative short assay times. 
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Fig. 6. Kinetics of analyte binding in wash-LOCI with the four insulin concentrations shown. 
The antibody pair used was HUI018-A beads/biotin-OXI005.  
 
 
Fig. 7. Kinetics of biotin-antibody binding in wash-LOCI. HUI018-A beads with biotin-
OXI005 (A), biotin-Fz (B), and biotin-Mill (C). The four insulin concentrations used were as 
shown.  
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Fig. 8. Kinetics of binding of SA-D beads in wash-LOCI. The antibody pair used was 
HUI018-A beads/biotin-OXI005 and the four insulin concentrations used are shown. 
The results of the investigation of the analyte binding are shown in Figure 6. The curves 
show that the analyte reaction had moved forward after 30 minutes and was still developing 
at 2 hours incubation. Longer incubation will give further increase in signal and 
improvement of sensitivity for some assays. However for practical reasons an incubation 
time of 1 hour was chosen. The fact that 1 hour of incubation may be needed in spite of the 
short diffusion distance to the bottom and in spite of the large surface-to-volume ratio may 
be explained by a relatively low antibody density on the bottom.  
The reaction was faster at higher insulin concentrations. The antibody density was lower than 
in LOCI because beads bound to the well bottoms only expose part of the coupled antibodies. 
Furthermore fewer beads were used per well in wash-LOCI compared to normal LOCI.  
Binding of biotin-OXI005 and biotin-Fz reached its maximum after 30 minutes; probably due 
to the high concentration of specific antibodies (Fig. 7 A and B). The biotin-Mill was 
obviously much slower in accordance with lower titer of this antibody (Fig. 7 C). As a 
compromise for the different antibodies a reaction time of 60 minutes was chosen as the 
standard condition, though after 15 minutes good assays were obtained. 
The kinetics of the SA-D beads was expected to be hampered by the size of the beads. The 
data show hat the binding of SA-D beads continued to increase from 5 minutes and to 40 
minutes (Fig. 9). The reaction did not develop further between 40 and 120 minutes (data not 
shown). For practical reasons and since the sensitivity of the assay was better after 60 
minutes, this time has been chosen as standard condition but good assays could also be 
obtained after 40 minutes incubation in this step. 
Based on the kinetics studies it can be seen that the assay, which presently run as a 3 hours 
assay, can be run with a total assay time of 1.5 hours ( sample 35 minutes, biotin antibody 15 
minutes and SA-D beads 45 minutes).  
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3.5 Reagent concentrations and amounts 
A sample volume of 10 µl was found to be the smallest volume able to cover the well bottom. 
Lower volumes will result in an uneven coating of the bottom. Higher volumes of sample 
will increase the reaction time. An amount of SA-D beads of 1 µg/well was found to give 
maximum signal in wash-LOCI (data not shown). Higher concentrations of SA-D beads did 
not increase the signal. The maximum amount of SA-D beads in LOCI is 2 µg. 
The effect of concentration (final) of biotin-antibodies on wash-LOCI and LOCI is shown in 
Figure 9. The results show that a higher concentration was required for the biotin-PCAs 
than for biotin-OXI005 to get maximum signal in the wash-LOCI. There was a slight increase 
in signal with increasing biotin-Fz concentration from 20 nM with maximum signal and 
sensitivity at 80 nM. With biotin-OXI005 the maximum signal was obtained between 6.65 
and 13.3 nM. With biotin-Mill the signal continued to increase up to at least 160 nM. The 
higher concentration needed for PCA is in accordance with the fact that only a smaller 
percentage of the IgG in PCA is specific antibodies. For both antibodies (Fz and Mill) 12 
µg/ml seemed to be suitable.  
 
Fig. 9. Biotin-antibody concentrations in wash-LOCI and LOCI both with HUI018-A beads. 
The biotin-antibody concentration is shown as final concentration in a well. The insulin 
concentration was, in all cases, 625 pM. 
It is clear that the wash-LOCI tolerated much higher concentrations of biotin-IgG than LOCI. 
With LOCI the signal was going down with higher concentrations of biotin-IgG. 
From Figure 9 it is clear that there was an upper limit for the concentration of the biotin-
antibody concentration in LOCI. The reason is a limiting amount of SA-D beads. The SA-D 
beads can not be increased to above 2 µg/well without signal reduction; probably due to 
optical effects. With this maximum concentration of SA-D the biotin-ab concentration 
should not be higher than 4.5 nM. Higher concentrations will reduce the signal. The 
decrease in signal was seen at the same concentration of biotin-OXI005, biotin-Fz and biotin-
Mill. This decrease limits the application of biotin-PCA in LOCI 
3.6 Hook effect and interference  
The sequential incubations in the wash-LOCI reduced interference from plasma samples 
and removed the risk of hook effect at high analyte concentrations. Figure 10 shows the 
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results of testing very high concentrations of insulin in wash-LOCI and LOCI. As expected 
there was no hook effect up to at least 100,000 pM with the wash-LOCI since excess 
unbound analyte was washed away prior to addition of biotin-antibody. The hook effect in 
the normal LOCI assays is seen at 30,000 pM. This hook effect was caused by excess insulin 
preventing sandwich formation. The difference between wash-LOCI and LOCI was not 
dramatic since LOCI has a very broad working range. However with even higher insulin 
concentrations the wash-LOCI has an advantage by not showing drop in signal at very high 
insulin concentrations. 
The plasma was affecting the antigen-antibody reactions and/or the signal. This effect is 
shown for wash-LOCI and LOCI with chicken plasma, rat plasma pig plasma compared to 
assay buffer (Fig. 11). In LOCI the effect of plasma compared to assay buffer was much more 
pronounced. Also there was more difference between calibration curves in plasma from 
different species. This difference in wash-LOCI between assay buffer and plasma may be 
due to the effect on the antigen-antibody reaction. 
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Fig. 10. Hook effect for wash-LOCI and LOCI. Antibody pairs were HUI001-A beads/biotin-
Fz in wash-LOCI and HUI018-A beads/biotin OXI005 in LOCI.  
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Fig. 11. Interference/matrix effects in wash-LOCI and LOCI both with HUI018-A 
beads/OXI005. Calibrators in assay buffer, chicken plasma, rat plasma, and pig plasma. 
The effect of hemolysis is caused by quenching of singlet oxygen and is thus affecting the 
signal output. This is in accordance with the limited effect in wash-LOCI compared to LOCI 
(Table 2). 
 
 
Table 2. Interference from hemoglobin in plasma. The assays were run with HUI018-A 
beads and biotin-OXI005. A chicken plasma sample spiked with 800 pM human insulin and 
with hemolysate of human erythrocytes to give the hemoglobin concentrations shown. 
It can be seen that the wash-LOCI tolerated up to 1500 mg hemoglobin/dl compared to 375 
mg/dl for the LOCI assay. The results with removal of hemolysate interference by washing 
show that the wash-LOCI may be used for samples containing interfering components. The 
wash-LOCI was more robust to plasma effect, singlet oxygen quenchers and inner filter 
effects. Only one of the antigen-antibody reactions was directly affected since plasma was 
washed away before the biotin-antibody was added and all plasma components were 
washed away before measurement. 
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3.7 Plate uniformity  
Reproducibility studies were performed by running a plate with the same sample (1000 pM 
of human insulin in chicken plasma) in all wells except for the two calibrator columns 11 
and 12. The variation in signal was 3.8% and there were no marked patterns on the plate. 
The wash-LOCI is more prone to variation than the homogenous version due to the plate 
coating and washing steps. It is important that the plate washer is washing all wells exactly 
the same way and that no or very little wash fluid is left in the wells.  
4. Conclusion  
This study has shown that the traditional homogeneous LOCI assay can be converted into a 
new semi-heterogeneous wash-LOCI which includes wash separation. Human insulin was 
used as a model analyte. LOCI and wash-LOCI were based on the same reagents and 
equipment. The only difference being that the antibody coated A-beads were anchored to 
the bottom of the plate wells in wash-LOCI. This anchoring allows introducing wash steps 
which will render the LOCI technology even more versatile. The assay worked (due to wash 
after biotin-antibody incubation) with not-immunopurified PCA. It was performed with the 
two antigen-antibody reactions as separate steps followed by addition of SA-D bead i.e. a 
sequential assay. Due to wash after sample incubation this assay was less prone to sample 
interferants. The signal was measured directly from the bottom of the well.  
Wash-LOCI assays showed very good sensitivity and a broad working range. It worked 
with low plasma sample volume (3 µl per well). The assay has a high capacity and may be 
run with the same equipment and on the same robotic lines as LOCI. With PCA and wash-
LOCI it may be possible to measure molecules which can not be measured in existing 
MCA/MCA assays. 
Wash-LOCI should be seen as a supplement to LOCI. It is very easy to switch from the no 
wash version to the wash version. However the normal LOCI is much easier to run and is a 
better assay so the wash-LOCI should only be considered for special purposes.  
The LOCI technology thus has the potential for non-separation-based (no-wash) and 
separation-based (wash) immunoassays. 
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